Thromboangiitis Obliterans (Buerger's Disease) in an Adolescent Male.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 08 2021
Historique:
received: 15 04 2020
accepted: 12 08 2020
pubmed: 15 9 2020
medline: 3 9 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Arterial occlusive disease of the limb is very rare in children. Buerger's disease (BD) is a nonatherosclerotic, segmental inflammatory arteritis affecting the small and medium-sized vessels of the extremities. We report BD in a 16-year-old male presenting with arterial insufficiency of left foot and history of smoking cigarettes and cannabis for 2 years. BD was diagnosed based on history of smoking in combination with clinical, laboratory, and radiologic findings. Pediatric hemato-oncologists should consider BD in the differential diagnosis in adolescents who smoke cigarettes and/or cannabis and present with vascular insufficiency of the hands and/or feet.

Identifiants

pubmed: 32925405
pii: 00043426-202108000-00012
doi: 10.1097/MPH.0000000000001933
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e759-e762

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Kayssi A, Shaikh F, Roche-Nagle G, et al. Management of acute limb ischemia in the pediatric population. J Vasc Surg. 2014;60:106–110.
Lim S, Javorski MJ, Halandras PM, et al. Epidemiology, treatment and outcomes of acute limb ischemia in the pediatric population. J Vasc Surg. 2018;68:182–188.
Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: diagnosis and treatment. Am Fam Physician. 2019;99:362–369.
Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med. 2000;343:864–869.
Vijayakumar A, Tiwari R, Prabhuswamy VK. Thromboangiitis obliterans (Buerger’s disease)—current practices. Int J Inflam. 2013;2013:156905.
Dardik H, Elias S, Miller N, et al. Medial approach to the anterior tibial artery. J Vasc Surg. 1985;2:743–746.
Joncour AL, Soudet S, Dupont A, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger’s disease): a multicenter study of 224 patients. J Am Heart Assoc. 2018;7:e010677.
Igari K, Inoue Y, Iwai T. The epidemiologic and clinical findings of patients with Buerger’s disease. Ann Vasc Surg. 2016;30:263–269.
Laslett LJ, Ikeda RM, Mason DT. Female adolescent Buerger’s disease: objective documentation and therapeutic remission. Am Heart J. 1981;102:452–456.
Matsushita M, Kuzuya A, Kobayashi M, et al. Buerger’s disease in a 19-year-old woman. J Vasc Surg. 2003;38:175–179.
Lavie G, Merdler I, Barenboim E, et al. A young adult male with peripheral artery disease. Acta Clin Belg. 2015;70:65–68.
Subramaniam VN, Menezes AR, DeSchutter A, et al. The cardiovascular effects of Marijuana: are the potential adverse effects worth the high? Missouri Med. 2019;116:146–153.
Martin-Blondel G, Koskas F, Cacoub P, et al. Is Thromboangiitis obliterans presentation influenced by cannabis addiction? Ann Vasc Surg. 2011;25:469–473.
Reid JL, Hammond D, Tariq U, et al. Tobacco Use in Canada: Patterns and Trends, 2019 Edition. Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo.
Ananth P, Reed-Weston A, Wolfe J. Medical marijuana in pediatric oncology: a review of the evidence and implications for practice. Pediatr Blood Cancer. 2018;65:e26826.
Bozkurt AK, Besirli K, Koksal C, et al. Surgical treatment of Buerger’s disease. Vascular. 2004;12:192–197.
Kim D, Ko YC, Ahn CM, et al. Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger’s disease. J Vasc Surg. 2018;67:1769–1777.

Auteurs

Stacy Chapman (S)

Division of Pediatric Hematology-Oncology.
Department of Pediatrics and Child Health.

Karen Ballinger (K)

Department of Pediatrics and Child Health.
Division of General Pediatrics.

Ming-Ka Chan (MK)

Department of Pediatrics and Child Health.
Division of General Pediatrics.

Camelia Stefanovici (C)

Department of Pediatrics and Child Health.
Departments of Pathology.

Katya Rozovsky (K)

Department of Pediatrics and Child Health.
Radiology.

April Boyd (A)

Division of Vascular Surgery, Department of Surgery, Health Sciences Center, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.

Magimairajan I Vanan (MI)

Division of Pediatric Hematology-Oncology.
Department of Pediatrics and Child Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH